Skip to content

Study on the clinical and mechanism of ''Tiaoshen liqi'' acupuncture in the treatment of mild depression

Study on the clinical and mechanism of ''Tiaoshen liqi'' acupuncture in the treatment of mild depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006378
Enrollment
Unknown
Registered
2022-07-25
Start date
2022-07-25
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mild depression

Interventions

Experimental group:"Tiaoshen liqi"acupuncture
Control group:Conventional acupuncture

Sponsors

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for mild depression of the International Classification of Diseases 10th revision (ICD-10). 2. Aged between 18 and 70 years. 3. The score of HDRS-24: 20 =HDRS= 26. 4. Patients who have not participated in other clinical trials within the last 1 month. 5. Patients who have not received treatment such as acupuncture and medication for depression within the last 1 week. 6. Patients who do not have aphasia or mental retardation, can understand the content of the scale and cooperate with 4 weeks of acupuncture treatment and follow-up for 3 months and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Meet the diagnostic criteria for schizophrenia, bipolar depression or other psychotic disorders with suicidal tendencies. 2. Patients with severe heart, liver, kidney and other systemic diseases. 3. Pregnant or lactating women. 4. Patients who cannot tolerate needling, or who have skin infection or breakdown at the site of needling, coagulation disorders, easy to get dizzy, or extreme weakness. 5. Patients who have participated in other clinical trials within 1 month prior to the start of this study. 6. Patients who have taken antidepressants or received acupuncture treatment for depression within 1 week prior to the start of this study. 7. Patients with severe cognitive and consciousness impairment that affects communication and unwillingness to cooperate, and who have not signed the informed consent form.

Design outcomes

Primary

MeasureTime frame
HDRS-24;

Secondary

MeasureTime frame
PHQ-9;WHOQOL-BREF;

Countries

China

Contacts

Public ContactWei Zou
kuangzou1965@163.com13351980999

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026